The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01674686
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01674686
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01674686. Randomized; single masking; primary purpose treatment. Start 2012-08-01 (actual); primary completion 2018-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
- Condition
- Variant Angina
- Intervention (Drug)
- Sarpogrelate
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct01674686- Content hash
9dd7202f6fdb0be1d11d996a2ca3ac71d8bdf4e071fe59691ae0682b3b973ad2